Leesol Overview

  • Year Founded
  • 2017

Year Founded

  • Status
  • Private

  • Employees
  • 12

Employees

  • Latest Deal Type
  • Series A2

  • Latest Deal Amount
  • $2.07M

  • Investors
  • 11

Leesol General Information

Description

Developer of an Artificial Intelligence based neuromodulation technology designed to provide prevention and treatment for healthy brains. The company creates devices for improving sleep disorders and preventing dementia using Transcranial Alternating Current Stimulation (tACS) type cranial electrical stimulation, enabling patients with sleep disorders to enhance sleep quality, reduce stress, and support mental balance.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • 24th floor, 7-8, Jungang-daero 214beongil
  • Dong-gu, Choryang-dong, Asti Hotel Busan
  • Busan
  • South Korea
+82
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Clinics/Outpatient Services
Corporate Office
  • 24th floor, 7-8, Jungang-daero 214beongil
  • Dong-gu, Choryang-dong, Asti Hotel Busan
  • Busan
  • South Korea
+82

Leesol Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Leesol Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Later Stage VC (Series A2) 19-Feb-2026 $2.07M Completed Generating Revenue
5. Later Stage VC (Series A) 02-Oct-2024 Completed Generating Revenue
4. Accelerator/Incubator Completed Generating Revenue
3. Accelerator/Incubator 31-Aug-2023 Completed Generating Revenue
2. Seed Round 18-May-2023 Completed Generating Revenue
1. Product Crowdfunding 08-Apr-2023 $5.91K Completed Generating Revenue
To view Leesol’s complete valuation and funding history, request access »

VC Exit Predictor

See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.

Opportunity Score

Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.

Exit Type

Evaluates the likelihood of a successful exit for investors, and the most likely exit type.

Leesol Patents

Leesol Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20260263735-A1 Method, device, and system for stimulating brain network Pending 10-Mar-2025
JP-2026149456-A Methods, devices, and systems for stimulating brain networks Pending 10-Mar-2025
JP-2026116780-A Method for providing biofeedback for personalized management, and user terminal and control method thereof. Pending 31-Dec-2024
US-20260183507-A1 Method for providing biofeedback for personalized management, user terminal, and method of controlling the user terminal Pending 31-Dec-2024
JP-2025105405-A Personalized brain stimulation device Active 28-Dec-2023 A61N1/36031
To view Leesol’s complete patent history, request access »

Leesol Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Leesol Investors (11)

Investor Name Investor Type Holding Investor Since Participating Rounds
BNK Venture Capital Venture Capital Minority
NAU IB Capital PE/Buyout Minority
Soo Investment Capital Venture Capital Minority
Spacetime Investment Corporate Venture Capital Minority
Alternative Investment Management Family Office Minority
You’re viewing 5 of 11 investors. Get the full list »

Leesol FAQs

  • When was Leesol founded?

    Leesol was founded in 2017.

  • Where is Leesol headquartered?

    Leesol is headquartered in Busan, South Korea.

  • What is the size of Leesol?

    Leesol has 12 total employees.

  • What industry is Leesol in?

    Leesol’s primary industry is Therapeutic Devices.

  • Is Leesol a private or public company?

    Leesol is a Private company.

  • What is Leesol’s current revenue?

    The current revenue for Leesol is .

  • How much funding has Leesol raised over time?

    Leesol has raised $5.07M.

  • Who are Leesol’s investors?

    BNK Venture Capital, NAU IB Capital, Soo Investment Capital, Spacetime Investment, and Alternative Investment Management are 5 of 11 investors who have invested in Leesol.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process